Friday, May 17, 2019 5:35:35 AM
And now, as we approach the final legs of submitting and then launching phase 3, the same big GLOBAL pharma has decided to embrace even more of the brilacidin franchise by including more indications. This is my guess.
So, to me, and actually several others I've read, believe it is not at all unusual to go this long, not only in preparing the next step for brilacidin OM phase 3 but also for the BP to remain anonymous under the CDA until they're ready to release the protocol and make final preps to launch the trial.
Just for notes...
I think some just don't have the patience, or tolerance, to believe things in this sector can take so long and if it doesn't fit their time line it must be falling apart or no longer valid.
What will be even more interesting is seeing where we go with Kevetrin. Will that be under the same BP as well?
From my sticky post, though I may make this one my new one. In fact will. I think things are about to get very exciting.
Best to all of us!!
$IPIX
"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM